ヒト母乳オリゴ糖の市場規模・シェア・展望・機会 (2022年～2030年)：用途・地域別

ヒト母乳オリゴ糖の健康上の利点に関する意識の高まりがヒト母乳オリゴ糖市場の成長を促進すると予想されています。また、食品サプリメントや機能性食品・飲料におけるヒト母乳オリゴ糖の使用の増加も市場成長を促進すると予測されています。一方で、母乳育児に関する意識の高まりや生産コストの高さが市場成長を抑制する見通しです。

当レポートでは、世界のヒト母乳オリゴ糖の市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、法規制環境、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 調査目的・前提条件

第2章 市場概要

第3章 市場力学・規制・動向分析

• 市場力学
• 影響分析
• 主なハイライト
• 規制シナリオ
• 製品の発売/承認
• PEST分析
• ポーターの分析
• M&Aシナリオ

第4章 世界のヒト母乳オリゴ糖市場：COVID-19の影響

• COVID-19：疫学
• 供給サイド・需要サイドの分析
• 経済的影響

第5章 世界のヒト母乳オリゴ糖市場：用途別

• 乳児用調製粉乳
• 栄養補助食品
• 機能性食品・飲料

第6章 世界のヒト母乳オリゴ糖市場：地域別

• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東・アフリカ
• その他の地域

第8章 競合情勢

• ZuChem Inc.
• Merck & Co. Inc.
• Hansen Holding AS
• Royal FrieslandCampina NV
• BASF
• IFF
• Gnubiotics
• Inbiose NV
• Carbosynth Holdings Limited
• Royal DSM N.V
• アナリストの見解

第9章 セクション

A major role in the infant's development is played by human milk oligosaccharides, which are structurally complex glycans found in breast milk. Human milk oligosaccharides (HMOs) are known to promote the growth of beneficial gut bacteria, stimulate the immune system, and aid brain development.

Market Dynamics:

Growing awareness regarding health benefits of human milk oligosaccharides is expected to drive market growth. Additionally, increasing use of HMOs in food supplements and functional food & beverage products is again projected to foster market growth. In May 2021, NewAge, Inc., announced the launch of Nutrifii Kids™ Chewable Multivitamin, a daily supplement for support of the healthy development and immune systems of children and adolescents.

On the other hand, growing awareness regarding breastfeeding and high cost of production is expected to restrict the growth of human milk oligosaccharides market.

Key features of the study:

• This report provides in-depth analysis of the global human milk oligosaccharides market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global human milk oligosaccharides market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include ZuChem Inc., Merck & Co. Inc., Chr. Hansen Holding AS (Jennewein Biotechnologie GmbH), Royal FrieslandCampina NV, BASF, IFF (DuPont Nutrition & Health), Gnubiotics, Inbiose NV, Carbosynth Holdings Limited, and Royal DSM N.V
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global human milk oligosaccharides market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global human milk oligosaccharides market

Detailed Segmentation:

• Global Human Milk Oligosaccharides Market, By Application:

• Infant Formula
• Dietary Supplements
• Functional Food and Beverage
• Global Human Milk Oligosaccharides Market, By Geography:

• North America
• Europe
• Asia-Pacific
• Rest of the World

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market HUMAN MILK OLIGOSACCHARIDES, By APPLICATION
  • Market HUMAN MILK OLIGOSACCHARIDES, By REGION
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Growing awareness regarding health benefits of HMO
  • High production cost
  • Integration of HMO in supplements and functional food
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Human Milk Oligosaccharides Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Human Milk Oligosaccharides Market, By Application, 2022-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• Infant Formula
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
• Dietary Supplements
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
• Functional Food and Beverage
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

6. Global Human Milk Oligosaccharides Market, By Region, 2022-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, By Country, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, For Country 2017-2028
  • Country Trends

7.

• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
• Middle East & Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
• Rest of World
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)

8. Competitive Landscape

• ZuChem Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck & Co. Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Hansen Holding AS
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Royal FrieslandCampina NV
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• BASF
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• IFF
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Gnubiotics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Inbiose NV
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Carbosynth Holdings Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Royal DSM N.V
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

9. Section

• Research Methodology
• About us